Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Accelerated Access Review

- PMLiVE

NICE backs GSK’s €594k gene therapy for rare disease

The treatment offers 'bubble baby' patients an alternative to a stem cell transplant

National Institute for Health and Care Excellence NICE logo

NICE to look again at Pfizer’s Besponsa after appeal

The blood cancer medicine was originally turned down on cost-effectiveness grounds

Novartis day

Novartis’ Extavia evades NICE restrictions on MS drugs

But Avonex, Plegridy, Betaferon, Rebif and Copaxone are set to be turned down

- PMLiVE

A unique ecosystem

How life science and healthcare clusters are driving innovation

- PMLiVE

Vivid MedComms bolster their business with a new senior appointment

A new hire for Vivid MedComms, part of the Lucid Group of companies

Lucid Group Communications Limited

- PMLiVE

When Dreams, Ambition and Talent Graduate

Last week saw the first intake into Lucid’s Futures Academy all graduate with full honours.

Lucid Group Communications Limited

Perspective on biotech leaders

In the latest issue of Perspective magazine, seven industry trailblazers reveal the trends, challenges and opportunities they anticipate in the biotech sector, from empowering patients to deciphering big data.

Blue Latitude Health

- PMLiVE

NICE set to reject wider use of Eisai’s Halaven

Issues draft guidance recommending against second-line use in breast cancer

- PMLiVE

Lucid’s magic touch attracts top talent to head their HR department

Ambition and talent are in abundance with Lucid’s new hire, Angela Young, HR Director

Lucid Group Communications Limited

Breakthrough innovation

The same key agile principles with a different twist

- PMLiVE

MHRA joins Instagram as part of Yellow Card drive

UK medicines regulator follows in the footsteps of NICE in using the channel

National Institute for Health and Care Excellence NICE logo

NICE backs two advanced breast cancer drugs after price cuts

An estimated 8,000 women will be eligible to receive the drugs due to discounts

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links